347 related articles for article (PubMed ID: 32097418)
1. Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?
Konert T; Everitt S; La Fontaine MD; van de Kamer JB; MacManus MP; Vogel WV; Callahan J; Sonke JJ
PLoS One; 2020; 15(2):e0228793. PubMed ID: 32097418
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
Carvalho S; Leijenaar RTH; Troost EGC; van Timmeren JE; Oberije C; van Elmpt W; de Geus-Oei LF; Bussink J; Lambin P
PLoS One; 2018; 13(3):e0192859. PubMed ID: 29494598
[TBL] [Abstract][Full Text] [Related]
3. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
[TBL] [Abstract][Full Text] [Related]
4. Pre-treatment
Ahn HK; Lee H; Kim SG; Hyun SH
Clin Radiol; 2019 Jun; 74(6):467-473. PubMed ID: 30898382
[TBL] [Abstract][Full Text] [Related]
5. Value of pre-therapy
Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
[TBL] [Abstract][Full Text] [Related]
6. Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions.
Kirienko M; Cozzi L; Rossi A; Voulaz E; Antunovic L; Fogliata A; Chiti A; Sollini M
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1649-1660. PubMed ID: 29623375
[TBL] [Abstract][Full Text] [Related]
7. Discovery of pre-therapy 2-deoxy-2-
Arshad MA; Thornton A; Lu H; Tam H; Wallitt K; Rodgers N; Scarsbrook A; McDermott G; Cook GJ; Landau D; Chua S; O'Connor R; Dickson J; Power DA; Barwick TD; Rockall A; Aboagye EO
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):455-466. PubMed ID: 30173391
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
Duan C; Chaovalitwongse WA; Bai F; Hippe DS; Wang S; Thammasorn P; Pierce LA; Liu X; You J; Miyaoka RS; Vesselle HJ; Kinahan PE; Rengan R; Zeng J; Bowen SR
Phys Med Biol; 2020 Oct; 65(20):205007. PubMed ID: 33027064
[TBL] [Abstract][Full Text] [Related]
9.
Liu F; Xiang Z; Li Q; Fang X; Zhou J; Yang X; Lin H; Yang Q
Clin Radiol; 2024 Jan; 79(1):e147-e155. PubMed ID: 37884401
[TBL] [Abstract][Full Text] [Related]
10. Integrating manual diagnosis into radiomics for reducing the false positive rate of
Kang F; Mu W; Gong J; Wang S; Li G; Li G; Qin W; Tian J; Wang J
Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2770-2779. PubMed ID: 31321483
[TBL] [Abstract][Full Text] [Related]
11. Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging.
Oliveira C; Amstutz F; Vuong D; Bogowicz M; Hüllner M; Foerster R; Basler L; Schröder C; Eboulet EI; Pless M; Thierstein S; Peters S; Hillinger S; Tanadini-Lang S; Guckenberger M
EJNMMI Res; 2021 Aug; 11(1):79. PubMed ID: 34417899
[TBL] [Abstract][Full Text] [Related]
12. Potential feature exploration and model development based on 18F-FDG PET/CT images for differentiating benign and malignant lung lesions.
Zhang R; Zhu L; Cai Z; Jiang W; Li J; Yang C; Yu C; Jiang B; Wang W; Xu W; Chai X; Zhang X; Tang Y
Eur J Radiol; 2019 Dec; 121():108735. PubMed ID: 31733432
[TBL] [Abstract][Full Text] [Related]
13. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281
[TBL] [Abstract][Full Text] [Related]
14. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
[TBL] [Abstract][Full Text] [Related]
15. A PET/CT radiomics model for predicting distant metastasis in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy: a multicentric study.
Yu L; Zhang Z; Yi H; Wang J; Li J; Wang X; Bai H; Ge H; Zheng X; Ni J; Qi H; Guan Y; Xu W; Zhu Z; Xing L; Dekker A; Wee L; Traverso A; Ye Z; Yuan Z
Radiat Oncol; 2024 Jan; 19(1):10. PubMed ID: 38254106
[TBL] [Abstract][Full Text] [Related]
16. Overall Survival Prognostic Modelling of Non-small Cell Lung Cancer Patients Using Positron Emission Tomography/Computed Tomography Harmonised Radiomics Features: The Quest for the Optimal Machine Learning Algorithm.
Amini M; Hajianfar G; Hadadi Avval A; Nazari M; Deevband MR; Oveisi M; Shiri I; Zaidi H
Clin Oncol (R Coll Radiol); 2022 Feb; 34(2):114-127. PubMed ID: 34872823
[TBL] [Abstract][Full Text] [Related]
17. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
Vuong D; Tanadini-Lang S; Huellner MW; Veit-Haibach P; Unkelbach J; Andratschke N; Kraft J; Guckenberger M; Bogowicz M
Med Phys; 2019 Apr; 46(4):1677-1685. PubMed ID: 30714158
[TBL] [Abstract][Full Text] [Related]
18. Use of radiomics based on
Zhou Y; Ma XL; Zhang T; Wang J; Zhang T; Tian R
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2904-2913. PubMed ID: 33547553
[TBL] [Abstract][Full Text] [Related]
19. [18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab.
Valentinuzzi D; Vrankar M; Boc N; Ahac V; Zupancic Z; Unk M; Skalic K; Zagar I; Studen A; Simoncic U; Eickhoff J; Jeraj R
Radiol Oncol; 2020 Jul; 54(3):285-294. PubMed ID: 32726293
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Computed Tomography and/or
Moran A; Wang Y; Dyer BA; Yip SSF; Daly ME; Yamamoto T
Clin Lung Cancer; 2021 Sep; 22(5):461-468. PubMed ID: 33931316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
